Civilization Ventures Achieves Major Win With NASDAQ Listing of Rocket Pharmaceuticals
Rocket Pharmaceuticals, Inc. (RCKT)
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
rocketpharma.com
Company Research
Source: Business Wire
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”) is an emerging multi-platform gene therapy company focused on developing first-in-class gene therapy treatments for rare, devastating diseases Civilization Ventures is a deep tech venture capital firm that has backed more than 20 companies since its inception in 2017, including Rocket Pharma SAN FRANCISCO--(BUSINESS WIRE)-- Deep-tech venture capital firm Civilization Ventures is announcing an important milestone in its portfolio as Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage biotechnology company focused on developing first-in-class gene therapy treatments for devastating rare diseases, reached and exceeded one billion dollars in market value for the first time in late Q3 2018. "The reality of gene therapies to revolutionize healthcare is here. We are excited to have backed R
Show less
Read more
Impact Snapshot
Event Time:
RCKT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCKT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCKT alerts
High impacting Rocket Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RCKT
News
- Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil [Yahoo! Finance]Yahoo! Finance
- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $53.00 price target on the stock.MarketBeat
- Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress [Yahoo! Finance]Yahoo! Finance
- Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent ProgressBusiness Wire
- Rocket Pharmaceuticals (RCKT) Upgraded to Buy: Here's Why [Yahoo! Finance]Yahoo! Finance
RCKT
Earnings
- 5/6/24 - Beat
RCKT
Sec Filings
- 5/7/24 - Form 10-Q
- 5/6/24 - Form 8-K
- 4/29/24 - Form ARS
- RCKT's page on the SEC website